Efficacy and Safety of Fondaparinux in Patients With Suspected Heparin-Induced Thrombocytopenia

Fondaparinux for the treatment of suspected heparin-induced thrombocytopenia: a propensity score-matched study

(2014) M. Kang et al.   BLOOD

Fondaparinux-associated heparin-induced thrombocytopenia

(2013) Vijaya R. Bhatt et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Diagnosis and Management of Heparin-Induced Thrombocytopenia

(2013) Grace M. Lee et al.   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Dynamic antibody-binding properties in the pathogenesis of HIT

(2012) B. S. Sachais et al.   BLOOD

Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE

(2011) Theodore E. Warkentin et al.   CHEST

Fondaparinux in acute heparin-induced thrombocytopenia: a case series

(2011) M. J. GOLDFARB et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series

(2011) T. E. WARKENTIN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin

(2011) Amani Al-Rossaies et al.   International Journal of Clinical Pharmacy